Regarding CYP2E1 expression, it is noteworthy that this enzyme is significantly over-expressed in Type 2 diabetics (86), potentially putting them at increased risk to the genetic effects of NDMA. Here, CYP2E1 is linked to type 2 diabetes mellitus.